What We Do
Commitment to Innovation
Commitment to Innovation
Commitment to Innovation
Welcome to Tackle Bio, Inc., a rapid drug development company. With a shared desire to find treatments for patients with COVID-19, We have identified and are strategically repurposing the most promising candidates. Our team has the expertise to make a difference in the lives of patients.
Our story
Commitment to Innovation
Commitment to Innovation
When the pandemic came to America in early 2020, there was much uncertainty about how widespread and deadly it would become. While many people felt confused or helpless, there were also many that wanted to pitch in and find solutions. Our team is made up of some those most talented solution seekers.
We're an experienced and talented group
When the pandemic came to America in early 2020, there was much uncertainty about how widespread and deadly it would become. While many people felt confused or helpless, there were also many that wanted to pitch in and find solutions. Our team is made up of some those most talented solution seekers.
We're an experienced and talented group of medical and scientific entrepreneurs with innovative solutions that we hope will contribute towards a better tomorrow.
our innovative solutions
Commitment to Innovation
our innovative solutions
At Tackle Bio, we are starting with drugs that are already approved for other indications to rapidly get them to patients while we use our expertise in drug design and delivery to optimize these therapeutics for enhanced efficacy. Unfortunately, COVID-19 is not going to disappear as quickly as other pandemics, and many patients are experi
At Tackle Bio, we are starting with drugs that are already approved for other indications to rapidly get them to patients while we use our expertise in drug design and delivery to optimize these therapeutics for enhanced efficacy. Unfortunately, COVID-19 is not going to disappear as quickly as other pandemics, and many patients are experiencing long-term complications after infection, or sequalae, which demand additional solutions. Our pipeline is intended to address the evolving medical challenges patients are experiencing now and in the near future.